nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—ALB—hepatitis B	0.783	1	CbGaD
Mirabegron—ORM1—saliva—hepatitis B	0.00638	0.363	CbGeAlD
Mirabegron—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00488	0.0244	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Entecavir—hepatitis B	0.00456	0.0228	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.0042	0.021	CcSEcCtD
Mirabegron—Nasopharyngitis—Telbivudine—hepatitis B	0.00417	0.0209	CcSEcCtD
Mirabegron—Gastritis—Telbivudine—hepatitis B	0.00413	0.0206	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00411	0.0206	CcSEcCtD
Mirabegron—Abdominal distension—Telbivudine—hepatitis B	0.00406	0.0203	CcSEcCtD
Mirabegron—Influenza—Telbivudine—hepatitis B	0.00403	0.0202	CcSEcCtD
Mirabegron—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.004	0.02	CcSEcCtD
Mirabegron—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00378	0.0189	CcSEcCtD
Mirabegron—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00377	0.0188	CcSEcCtD
Mirabegron—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00376	0.0188	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00375	0.0187	CcSEcCtD
Mirabegron—Back pain—Adefovir Dipivoxil—hepatitis B	0.00323	0.0161	CcSEcCtD
Mirabegron—Connective tissue disorder—Telbivudine—hepatitis B	0.00317	0.0159	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00289	0.0145	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00282	0.0141	CcSEcCtD
Mirabegron—Infection—Entecavir—hepatitis B	0.00277	0.0139	CcSEcCtD
Mirabegron—Back pain—Telbivudine—hepatitis B	0.00272	0.0136	CcSEcCtD
Mirabegron—Skin disorder—Entecavir—hepatitis B	0.00271	0.0136	CcSEcCtD
Mirabegron—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00264	0.0132	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00248	0.0124	CcSEcCtD
Mirabegron—Dyspepsia—Entecavir—hepatitis B	0.00246	0.0123	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Entecavir—hepatitis B	0.00241	0.0121	CcSEcCtD
Mirabegron—Fatigue—Entecavir—hepatitis B	0.00241	0.012	CcSEcCtD
Mirabegron—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.0024	0.012	CcSEcCtD
Mirabegron—Arthralgia—Telbivudine—hepatitis B	0.00239	0.012	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00237	0.0119	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00237	0.0118	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00235	0.0118	CcSEcCtD
Mirabegron—Nasopharyngitis—Lamivudine—hepatitis B	0.00235	0.0118	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00232	0.0116	CcSEcCtD
Mirabegron—Abdominal distension—Lamivudine—hepatitis B	0.00229	0.0114	CcSEcCtD
Mirabegron—Gastrointestinal pain—Entecavir—hepatitis B	0.00228	0.0114	CcSEcCtD
Mirabegron—Influenza—Lamivudine—hepatitis B	0.00227	0.0114	CcSEcCtD
Mirabegron—Skin disorder—Telbivudine—hepatitis B	0.00223	0.0111	CcSEcCtD
Mirabegron—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00223	0.0111	CcSEcCtD
Mirabegron—Abdominal pain—Entecavir—hepatitis B	0.00221	0.011	CcSEcCtD
Mirabegron—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00215	0.0108	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00209	0.0104	CcSEcCtD
Mirabegron—Dyspepsia—Telbivudine—hepatitis B	0.00202	0.0101	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00201	0.01	CcSEcCtD
Mirabegron—Asthenia—Entecavir—hepatitis B	0.002	0.01	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00198	0.0099	CcSEcCtD
Mirabegron—Fatigue—Telbivudine—hepatitis B	0.00198	0.00989	CcSEcCtD
Mirabegron—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00195	0.00977	CcSEcCtD
Mirabegron—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00193	0.00964	CcSEcCtD
Mirabegron—Diarrhoea—Entecavir—hepatitis B	0.00191	0.00955	CcSEcCtD
Mirabegron—Sinusitis—Lamivudine—hepatitis B	0.0019	0.00951	CcSEcCtD
Mirabegron—Gastrointestinal pain—Telbivudine—hepatitis B	0.00187	0.00938	CcSEcCtD
Mirabegron—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00186	0.00932	CcSEcCtD
Mirabegron—Dizziness—Entecavir—hepatitis B	0.00184	0.00923	CcSEcCtD
Mirabegron—Rhinitis—Lamivudine—hepatitis B	0.00182	0.00912	CcSEcCtD
Mirabegron—Abdominal pain—Telbivudine—hepatitis B	0.00181	0.00906	CcSEcCtD
Mirabegron—Connective tissue disorder—Lamivudine—hepatitis B	0.00179	0.00894	CcSEcCtD
Mirabegron—Rash—Entecavir—hepatitis B	0.00176	0.0088	CcSEcCtD
Mirabegron—Dermatitis—Entecavir—hepatitis B	0.00176	0.00879	CcSEcCtD
Mirabegron—Headache—Entecavir—hepatitis B	0.00175	0.00874	CcSEcCtD
Mirabegron—BCHE—blood plasma—hepatitis B	0.00172	0.0978	CbGeAlD
Mirabegron—Erythema multiforme—Lamivudine—hepatitis B	0.00172	0.0086	CcSEcCtD
Mirabegron—Rash—Adefovir Dipivoxil—hepatitis B	0.00172	0.00859	CcSEcCtD
Mirabegron—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00171	0.00858	CcSEcCtD
Mirabegron—Headache—Adefovir Dipivoxil—hepatitis B	0.00171	0.00853	CcSEcCtD
Mirabegron—Nausea—Entecavir—hepatitis B	0.00166	0.00829	CcSEcCtD
Mirabegron—Asthenia—Telbivudine—hepatitis B	0.00164	0.00823	CcSEcCtD
Mirabegron—Pruritus—Telbivudine—hepatitis B	0.00162	0.00811	CcSEcCtD
Mirabegron—Nausea—Adefovir Dipivoxil—hepatitis B	0.00162	0.00809	CcSEcCtD
Mirabegron—Diarrhoea—Telbivudine—hepatitis B	0.00157	0.00785	CcSEcCtD
Mirabegron—Back pain—Lamivudine—hepatitis B	0.00153	0.00766	CcSEcCtD
Mirabegron—Dizziness—Telbivudine—hepatitis B	0.00152	0.00758	CcSEcCtD
Mirabegron—Rash—Telbivudine—hepatitis B	0.00145	0.00723	CcSEcCtD
Mirabegron—Dermatitis—Telbivudine—hepatitis B	0.00144	0.00722	CcSEcCtD
Mirabegron—Headache—Telbivudine—hepatitis B	0.00144	0.00718	CcSEcCtD
Mirabegron—Nausea—Telbivudine—hepatitis B	0.00136	0.00681	CcSEcCtD
Mirabegron—Arthralgia—Lamivudine—hepatitis B	0.00135	0.00674	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00134	0.00669	CcSEcCtD
Mirabegron—Dry mouth—Lamivudine—hepatitis B	0.00132	0.00659	CcSEcCtD
Mirabegron—Infection—Lamivudine—hepatitis B	0.00128	0.00642	CcSEcCtD
Mirabegron—Skin disorder—Lamivudine—hepatitis B	0.00125	0.00628	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00118	0.00589	CcSEcCtD
Mirabegron—CYP3A4—blood plasma—hepatitis B	0.00116	0.0659	CbGeAlD
Mirabegron—CYP2D6—blood plasma—hepatitis B	0.00114	0.0648	CbGeAlD
Mirabegron—Dyspepsia—Lamivudine—hepatitis B	0.00114	0.00569	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00112	0.00558	CcSEcCtD
Mirabegron—Fatigue—Lamivudine—hepatitis B	0.00111	0.00557	CcSEcCtD
Mirabegron—Constipation—Lamivudine—hepatitis B	0.0011	0.00553	CcSEcCtD
Mirabegron—Gastrointestinal pain—Lamivudine—hepatitis B	0.00106	0.00528	CcSEcCtD
Mirabegron—Urticaria—Lamivudine—hepatitis B	0.00103	0.00513	CcSEcCtD
Mirabegron—Abdominal pain—Lamivudine—hepatitis B	0.00102	0.00511	CcSEcCtD
Mirabegron—ORM1—blood—hepatitis B	0.00102	0.0578	CbGeAlD
Mirabegron—Asthenia—Lamivudine—hepatitis B	0.000927	0.00464	CcSEcCtD
Mirabegron—Pruritus—Lamivudine—hepatitis B	0.000914	0.00457	CcSEcCtD
Mirabegron—Diarrhoea—Lamivudine—hepatitis B	0.000884	0.00442	CcSEcCtD
Mirabegron—Dizziness—Lamivudine—hepatitis B	0.000854	0.00427	CcSEcCtD
Mirabegron—ABCB1—blood plasma—hepatitis B	0.00082	0.0466	CbGeAlD
Mirabegron—Rash—Lamivudine—hepatitis B	0.000814	0.00407	CcSEcCtD
Mirabegron—Dermatitis—Lamivudine—hepatitis B	0.000814	0.00407	CcSEcCtD
Mirabegron—Headache—Lamivudine—hepatitis B	0.000809	0.00405	CcSEcCtD
Mirabegron—ORM1—liver—hepatitis B	0.000795	0.0452	CbGeAlD
Mirabegron—Nausea—Lamivudine—hepatitis B	0.000767	0.00384	CcSEcCtD
Mirabegron—SLCO1A2—liver—hepatitis B	0.000701	0.0399	CbGeAlD
Mirabegron—ALB—liver—hepatitis B	0.000697	0.0396	CbGeAlD
Mirabegron—BCHE—blood—hepatitis B	0.00063	0.0358	CbGeAlD
Mirabegron—BCHE—liver—hepatitis B	0.000493	0.028	CbGeAlD
Mirabegron—CYP3A4—blood—hepatitis B	0.000424	0.0241	CbGeAlD
Mirabegron—CYP2D6—blood—hepatitis B	0.000418	0.0237	CbGeAlD
Mirabegron—CYP3A4—liver—hepatitis B	0.000332	0.0189	CbGeAlD
Mirabegron—CYP2D6—liver—hepatitis B	0.000327	0.0186	CbGeAlD
Mirabegron—ABCB1—blood—hepatitis B	0.0003	0.0171	CbGeAlD
Mirabegron—ABCB1—liver—hepatitis B	0.000235	0.0134	CbGeAlD
